State Street Corp. Discloses Passive Stake in Arcus Biosciences
Ticker: RCUS · Form: SC 13G · Filed: Jan 24, 2024 · CIK: 1724521
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, passive-investment, SC-13G
TL;DR
**State Street just revealed a passive stake in Arcus Biosciences, signaling institutional interest.**
AI Summary
State Street Corporation, a major financial institution, has filed an initial SC 13G indicating its ownership of Arcus Biosciences, Inc. common stock as of December 31, 2023. This filing, made under Rule 13d-1(b), signifies that State Street holds a passive investment in Arcus Biosciences. For investors, this means a large institutional player sees value in Arcus Biosciences, potentially adding a layer of stability or validation to the stock, though the exact percentage of ownership is not disclosed in the provided snippet.
Why It Matters
Institutional ownership by a firm like State Street can signal confidence in a company's long-term prospects, which might positively influence investor sentiment for Arcus Biosciences.
Risk Assessment
Risk Level: low — This filing indicates a passive investment by a large institution, which generally reduces perceived risk rather than increasing it.
Analyst Insight
An investor might consider this filing as a positive signal of institutional interest in Arcus Biosciences, but should await further details on the exact percentage of ownership and State Street's investment thesis before making any significant investment decisions.
Key Players & Entities
- State Street Corporation (company) — reporting person and institutional investor
- Arcus Biosciences, Inc. (company) — subject company whose stock is being reported
- 04-2456637 (person) — IRS Identification No. for State Street Corporation
- December 31, 2023 (dollar_amount) — date of event which requires filing
FAQ
What type of filing is this document?
This document is an SC 13G, specifically an 'INITIAL FILING' under the Securities Exchange Act of 1934, as stated in the filing's title and body.
Who is the reporting person in this SC 13G filing?
The reporting person is STATE STREET CORPORATION, as clearly identified under '1. NAME OF REPORTING PERSON' on page 2 of 5.
What is the subject company whose securities are being reported?
The subject company is ARCUS BIOSCIENCES INC, as indicated under 'NAME OF ISSUER' on page 1 of 5.
What is the CUSIP number for the class of securities reported?
The CUSIP number for the Common Stock of Arcus Biosciences Inc. is 03969F109, as listed on page 1 of 5 and page 2 of 5.
What was the date of the event that triggered this filing?
The date of the event which requires the filing of this statement was 12/31/2023, as specified on page 1 of 5.
Filing Details
This Form SC 13G (Form SC 13G) was filed with the SEC on January 24, 2024 by 04-2456637 regarding Arcus Biosciences, Inc. (RCUS).